CervoMed Inc. Interest Income (Expense), Nonoperating, Net
CervoMed Inc. (CRVO) reported Interest Income (Expense), Nonoperating, Net of $179.46 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2023-08-08
- CervoMed Inc. interest income (expense), nonoperating, net for the quarter ending 2023-06-30 was $179.46K, a 224.06% increase year-over-year.
- CervoMed Inc. interest income (expense), nonoperating, net for the quarter ending 2023-03-31 was $173.90K, a 525.33% increase year-over-year.
- CervoMed Inc. interest income (expense), nonoperating, net for the quarter ending 2022-12-31 was $172.85K.
- CervoMed Inc. interest income (expense), nonoperating, net for the quarter ending 2022-09-30 was $124.71K, a 145.93% increase year-over-year.
- CervoMed Inc. interest income (expense), nonoperating, net for fiscal 2022 was $380.75K, a 176.94% increase from fiscal 2021.
- CervoMed Inc. interest income (expense), nonoperating, net for fiscal 2021 was $137.49K, a 20.33% increase from fiscal 2020.
- CervoMed Inc. interest income (expense), nonoperating, net for fiscal 2020 was $114.26K, a 33.94% increase from fiscal 2019.
- CervoMed Inc. interest income (expense), nonoperating, net for fiscal 2019 was $85.30K, a 43.75% decline from fiscal 2018.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 3 month as first filed | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | $179.46K 10-Q · filed 2023-08-08 | $353.35K 10-Q · filed 2023-08-08 | $526.21K derived: sum of 3 quarters · filed 2023-08-08 | $650.92K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2023-03-31 | $173.90K 10-Q · filed 2023-05-15 | $346.75K derived: sum of 2 quarters · filed 2023-05-15 | $471.46K derived: sum of 3 quarters · filed 2023-05-15 | $526.84K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-12-31 | $172.85K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $297.56K derived: sum of 2 quarters · filed 2023-03-24 | $352.94K derived: sum of 3 quarters · filed 2023-08-08 | $380.75K 10-K · filed 2023-03-24 | |
| 2022-09-30 | $124.71K 10-Q · filed 2022-11-14 | $180.09K derived: sum of 2 quarters · filed 2023-08-08 | $207.90K 10-Q · filed 2022-11-14 | $199.03K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-06-30 | $55.38K 10-Q · filed 2023-08-08 | $83.19K 10-Q · filed 2023-08-08 | $74.32K derived: sum of 3 quarters · filed 2023-08-08 | $125.03K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $27.81K 10-Q · filed 2023-05-15 | $18.94K derived: sum of 2 quarters · filed 2023-05-15 | $69.65K derived: sum of 3 quarters · filed 2023-05-15 | $124.88K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$8.87K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $41.84K derived: sum of 2 quarters · filed 2023-03-24 | $97.07K derived: sum of 3 quarters · filed 2023-03-24 | $137.49K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $50.71K 10-Q · filed 2022-11-14 | $105.94K derived: sum of 2 quarters · filed 2022-11-14 | $146.35K 10-Q · filed 2022-11-14 | $171.37K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $55.23K 10-Q · filed 2022-08-12 | $95.64K 10-Q · filed 2022-08-12 | $120.66K derived: sum of 3 quarters · filed 2022-08-12 | $149.89K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $40.42K 10-Q · filed 2022-05-12 | -$40.42K 10-Q · filed 2021-05-07 | $65.43K derived: sum of 2 quarters · filed 2022-05-12 | $94.66K derived: sum of 3 quarters · filed 2022-05-12 | $120.57K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $25.01K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $54.24K derived: sum of 2 quarters · filed 2022-03-18 | $80.16K derived: sum of 3 quarters · filed 2022-03-18 | $114.26K 10-K · filed 2022-03-18 | |
| 2020-09-30 | $29.23K 10-Q · filed 2021-11-10 | $55.15K derived: sum of 2 quarters · filed 2021-11-10 | $89.25K 10-Q · filed 2021-11-10 | $46.75K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $25.91K 10-Q · filed 2021-08-11 | $60.01K 10-Q · filed 2021-08-11 | $17.52K derived: sum of 3 quarters · filed 2021-08-11 | $39.51K derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | -$34.10K 10-Q · filed 2021-05-07 | $34.10K 10-Q · filed 2020-05-11 | -$8.39K derived: sum of 2 quarters · filed 2021-05-07 | $13.60K derived: sum of 3 quarters · filed 2021-05-07 | $30.52K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $25.71K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $47.70K derived: sum of 2 quarters · filed 2021-03-17 | $64.62K derived: sum of 3 quarters · filed 2021-03-17 | $85.30K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $21.99K 10-Q · filed 2020-11-12 | $38.91K derived: sum of 2 quarters · filed 2020-11-12 | $59.60K 10-Q · filed 2020-11-12 | $90.46K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $16.92K 10-Q · filed 2020-08-07 | $37.60K 10-Q · filed 2020-08-07 | $68.47K derived: sum of 3 quarters · filed 2020-08-07 | $106.45K derived: sum of 4 quarters · filed 2020-08-07 | |
| 2019-03-31 | $20.68K 10-Q · filed 2020-05-11 | $51.55K derived: sum of 2 quarters · filed 2020-05-11 | $89.53K derived: sum of 3 quarters · filed 2020-05-11 | $134.87K derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $30.86K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $68.84K derived: sum of 2 quarters · filed 2020-03-17 | $114.18K derived: sum of 3 quarters · filed 2020-03-17 | $151.65K 10-K · filed 2020-03-17 | |
| 2018-09-30 | $37.98K 10-Q · filed 2019-11-08 | $83.32K derived: sum of 2 quarters · filed 2019-11-08 | $120.78K 10-Q · filed 2019-11-08 | $146.07K derived: sum of 4 quarters · filed 2019-11-08 | |
| 2018-06-30 | $45.34K 10-Q · filed 2019-08-08 | $82.80K 10-Q · filed 2019-08-08 | $108.09K derived: sum of 3 quarters · filed 2019-08-08 | $109.41K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | $37.46K 10-Q · filed 2019-05-09 | $62.75K derived: sum of 2 quarters · filed 2019-05-09 | $64.07K derived: sum of 3 quarters · filed 2019-05-09 | $45.18K derived: sum of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | $25.28K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $26.60K derived: sum of 2 quarters · filed 2019-03-19 | $7.71K derived: sum of 3 quarters · filed 2019-03-19 | -$48.01K 10-K · filed 2019-03-19 | |
| 2017-09-30 | $1.32K 10-Q · filed 2018-11-13 | -$17.57K derived: sum of 2 quarters · filed 2018-11-13 | -$73.29K 10-Q · filed 2018-11-13 | -$102.12K derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | -$18.89K 10-Q · filed 2018-08-10 | -$74.61K 10-Q · filed 2018-08-10 | -$103.44K derived: sum of 3 quarters · filed 2018-08-10 | -$104.82K derived: sum of 4 quarters · filed 2018-08-10 | |
| 2017-03-31 | -$55.72K 10-Q · filed 2018-05-10 | -$84.55K derived: sum of 2 quarters · filed 2018-05-10 | -$85.93K derived: sum of 3 quarters · filed 2018-05-10 | ||
| 2016-12-31 | -$28.83K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$30.21K derived: sum of 2 quarters · filed 2018-04-02 | -$29.69K 10-K · filed 2018-04-02 | ||
| 2016-09-30 | -$1.38K 10-Q · filed 2017-11-13 | -$854.00 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |